Daniel Gibson
Founder presso TELESIS BIO, INC.
Patrimonio netto: 46 447 $ in data 31/03/2024
Profilo
Daniel G.
Gibson is the founder of Telesis Bio, Inc. (founded in 2011) where he holds the title of Chief Technology Officer.
He also held the position of Vice President-DNA Technology at Viridos, Inc. from 2011 to 2018.
Additionally, he was a Professor at J.
Craig Venter Institute, Inc. Dr. Gibson holds a doctorate degree from the University of Southern California and an undergraduate degree from the State University of New York at Buffalo.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
TELESIS BIO, INC.
0.35% | 01/03/2024 | 105 562 ( 0.35% ) | 46 447 $ | 31/03/2024 |
Posizioni attive di Daniel Gibson
Società | Posizione | Inizio |
---|---|---|
TELESIS BIO, INC. | Founder | 24/03/2011 |
Precedenti posizioni note di Daniel Gibson
Società | Posizione | Fine |
---|---|---|
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/08/2018 |
J. Craig Venter Institute, Inc.
J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Formazione di Daniel Gibson
University of Southern California | Doctorate Degree |
State University of New York at Buffalo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TELESIS BIO, INC. | Commercial Services |
Aziende private | 2 |
---|---|
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Commercial Services |
J. Craig Venter Institute, Inc.
J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Commercial Services |
- Borsa valori
- Insiders
- Daniel Gibson